Price & resources

SUBLOCADE pricing

What to know about paying for
SUBLOCADE.

Pay as little as $5 per monthly dose of SUBLOCADE, if eligible.*

There is copay assistance offered through the INSUPPORT® Copay Assistance Program, which may help eligible patients with their out-of-pocket costs for SUBLOCADE. If a patient is eligible for copay assistance, they may pay as little as $5 per monthly dose of SUBLOCADE. For the first two doses of each calendar year, an expanded copay assistance amount of up to the list price of SUBLOCADE is provided. Following the first two doses, the copay for subsequent doses for the remainder of the calendar year may be reduced. The expanded copay assistance of up to the list price resets at the beginning of the calendar year. The program is applicable to medical expenses of the drug, not administration costs. If you have additional questions about copay, download the Copay FAQs Brochure.

Complete the INSUPPORT® Patient Enrollment Form with a healthcare provider. A healthcare provider will submit this form. INSUPPORT® Hub Services may provide information on insurance coverage and copay assistance for SUBLOCADE.

*The INSUPPORT® Copay Assistance Program is valid ONLY for patients with private insurance who are prescribed SUBLOCADE® (buprenorphine extended-release) for on-label use. Patients with government insurance are not eligible for the Copay Assistance Program, including, but not limited to, Medicare, Medicaid, Medigap, VA, DOD, TriCare, CHAMPVA, or any other federally or state-funded government-assisted program. Other restrictions apply. See here for full Terms & Conditions.

Find a buprenorphine treatment provider

UNDERSTANDING THE PRICE FOR SUBLOCADE®‡

It can be hard to understand what you have to pay for the medicines that you are prescribed. Depending on insurance coverage, coupon offers, and other savings tools, people may end up paying different out-of-pocket amounts.

The list price* of SUBLOCADE (for both 300 mg and 100 mg dosage forms) is $1659 per month. However, most people will not pay this amount.

If you have commercial insurance

You could pay between $1 and $2400 per month, with the average out-of-pocket cost for SUBLOCADE itself being $248.10 or less.

If you have Medicare

You could pay between $3.70 and $1913.50 per dose (whether 300 mg or 100 mg) if you are receiving SUBLOCADE once monthly (depending on your specific Medicare benefits), with the average out-of-pocket cost of SUBLOCADE itself being $75.70 or less. If you have Medicare Part B, you may also have a supplemental insurance plan that will pay all or part of your SUBLOCADE costs. If you have Medicare Part C, there is an out-of-pocket maximum and what you will pay for SUBLOCADE depends on your plan's benefit design and the level of other healthcare expenses you have during the year. Please check with your Medicare plan administrator for further details.

If you have Medicaid

You could pay between $0.50 and $30 per month, (depending on the state plan), with the average out-of-pocket cost of SUBLOCADE itself being $3.24 or less. To find out if you qualify for Medicaid, or to get more information about copayments in your state, please use this link to visit the Medicaid website.

If you do not have insurance coverage

If you do not have medical coverage for SUBLOCADE, you can expect to pay the list price shown above.

Talk to your insurance provider for the most accurate information for you.

*An estimate of the manufacturer's list price for a drug to wholesalers or other direct purchasers, not including discounts or rebates. This price is defined by federal law. This information is accurate as of Jan 1, 2020. The list prices listed may differ significantly from actual prices paid by customers and consumers. In addition, a product's list price is typically not associated with per-dose pricing and does not necessarily reflect price per dosage or price per course of treatment.

Symphony Health, PayerSource®, September 2018 – August 2019. Calculations were based on a survey of pharmacy and medical claim amounts for SUBLOCADE alone, examining 79 managed care commercial plans, 17 Medicare managed care plans, and between 21-71 Medicaid managed care plans prior to any discounts or copay card applications, and exclude zero dollar claims and data outliers.

Indivior cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record.

Want information?

Find out more about opioid addiction and treating it.

Get Updates

IMPORTANT SAFETY INFORMATION AND INDICATION

What is the most important information I should know about SUBLOCADE?

Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.

In an emergency, you or your family should tell the emergency medical staff that you are physically dependent on an opioid and are being treated with SUBLOCADE.

Buprenorphine, the medicine in SUBLOCADE, can cause serious and life-threatening problems, especially if you take or use certain other medicines or drugs. Call your healthcare provider right away or get emergency help if you:

These can be signs of an overdose or other serious problems.

Death or serious harm, including life-threatening breathing problems, can happen if you take anxiety medicines or benzodiazepines, sleeping pills, tranquilizers, muscle relaxants, or sedatives, antidepressants, or antihistamines, or drink alcohol during treatment with SUBLOCADE. Tell your healthcare provider if you are taking any of these medicines and if you drink alcohol.

SUBLOCADE is a controlled substance (CIII) because it contains buprenorphine that can be a target for people who abuse prescription medicines or street drugs.

Death has been reported in those who are not opioid dependent who received buprenorphine sublingually.

Do not use SUBLOCADE if you are allergic to buprenorphine or any ingredient in the prefilled syringe (ATRIGEL® Delivery System, a biodegradable 50:50 poly(DL-lactide-co-glycolide) polymer and a biocompatible solvent, N-methyl-2-pyrrolidone (NMP)).

SUBLOCADE may not be right for you. Before starting SUBLOCADE, tell your healthcare provider about all of your medical conditions, including:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. SUBLOCADE may affect the way other medicines work and other medicines may affect how SUBLOCADE works. Some medicines may cause serious or life-threatening medical problems when taken with SUBLOCADE. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist each time you get a new medicine.

The doses of certain medicines may need to be changed if used during treatment with SUBLOCADE. Do not take any medicine during treatment with SUBLOCADE until you have talked with your healthcare provider. Your healthcare provider will tell you if it is safe to take other medicines during treatment with SUBLOCADE.

You should not take anxiety medicines or benzodiazepines (such as Valium® or Xanax®), sleeping pills, tranquilizers, muscle relaxants, or sedatives (such as Ambien®), antidepressants, or antihistamines that are not prescribed to you during treatment with SUBLOCADE, as this can lead to slowed breathing, drowsiness, delayed reaction time, loss of consciousness or even death. If a healthcare provider is considering prescribing such a medicine for you, remind the healthcare provider that you are being treated with SUBLOCADE.

You may have detectable levels of SUBLOCADE in your body for a long period after stopping treatment with SUBLOCADE.

What should I avoid while being treated with SUBLOCADE?

What are the possible side effects of SUBLOCADE?

SUBLOCADE can cause serious side effects, including:

These symptoms may start weeks to months after your last dose of SUBLOCADE.

Your healthcare provider may do tests before and during treatment with SUBLOCADE to check your liver.

These are not all the possible side effects. Call your healthcare provider for medical advice about side effects.

To report pregnancy or side effects associated with taking SUBLOCADE, please call 1-877-782-6966. You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Indication

SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for at least 7 days. SUBLOCADE is part of a complete treatment plan that should include counseling.

For more information about SUBLOCADE, see the full Prescribing Information including BOXED WARNING, and Medication Guide or talk to your healthcare provider. For REMS information visit www.sublocadeREMS.com.